Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician. Issue 13 (July 2019)

• Record Type: Journal Article
• Authors: Perez, Irving E; Taveras Alam, Sara; Hernandez, Gabriel A; Sancassani, Rhea
• Is Part Of: Clinical Medicine Insights. Issue 13(2019)
• Publication Date: 2019-07
• Subjects: Cardiotoxicity -- cardiac dysfunction -- heart failure -- cardio-oncology; Cardiovascular system -- Diseases -- Periodicals; Cardiology -- Periodicals; Cardiovascular Diseases; Cardiology; Cardiovascular system -- Diseases; Electronic journals; Periodicals; Fulltext; Internet Resources; Periodicals; Periodicals; 616.12
• DOI: 10.1177/1179546819866445
• Languages: English
• ISSNs: 1179-5468

Abstract

Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, either case being potentially permanent or reversible. Risk assessment, recognition, and prevention of CTRCD are crucial.